Factor V Leiden mutation: a treatable etiology for sporadic and recurrent pregnancy loss

Fertility and Sterility

Volumn 89, Issue 2, 2008, Pages 410-416

  Glueck, Charles J ^a   Gogenini, Srikant ^a   Munjal, Jitender ^a   Tracy, Trent ^a   Pranikoff, Joel ^a   Wang, Ping ^a  

^a JEWISH HOSPITAL   (United States)

Author keywords

Factor V Leiden (FVL) mutation; recurrent pregnancy loss (RPL); sporadic pregnancy loss

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA EXTRACTION; FEMALE; FETUS WASTAGE; GENE MUTATION; GENETIC HETEROGENEITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECURRENT PREGNANCY LOSS; RISK ASSESSMENT; THROMBOPHILIA; THROMBOSIS PREVENTION;

ABORTION, HABITUAL; AGE DISTRIBUTION; ANTICOAGULANTS; CASE-CONTROL STUDIES; EMBRYO LOSS; FACTOR V; FEMALE; GENE FREQUENCY; GESTATIONAL AGE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MUTATION; PREGNANCY; PREGNANCY MAINTENANCE; THROMBOPHILIA;

EID: 38949103023     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.03.011     Document Type: Article

References (54)

1. Paidas M.J., Ku D.H., and Arkel Y.S. Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome. Clin Perinatol 31 (2004) 783-805
2. Vossen C.Y., Preston F.E., Conard J., Fontcuberta J., Makris M., van der Meer F.J., et al. Hereditary thrombophilia and fetal loss: a prospective follow-up study. J Thromb Haemost 2 (2004) 592-596
3. Glueck C.J., Wang P., Bornovali S., Goldenberg N., and Sieve L. Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss. Metabolism 52 (2003) 1627-1632
4. Kovalevsky G., Gracia C.R., Berlin J.A., Sammel M.D., and Barnhart K.T. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Arch Intern Med 164 (2004) 558-563
5. Younis J.S., Brenner B., Ohel G., Tal J., Lanir N., and Ben-Ami M. Activated protein C resistance and factor V Leiden mutation can be associated with first- as well as second-trimester recurrent pregnancy loss. Am J Reprod Immunol 43 (2000) 31-35
6. Murphy R.P., Donoghue C., Nallen R.J., D'Mello M., Regan C., Whitehead A.S., et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol 20 (2000) 266-270
7. Blumenfeld Z., and Brenner B. Thrombophilia-associated pregnancy wastage. Fertil Steril 72 (1999) 765-774
8. Tal J., Schliamser L.M., Leibovitz Z., Ohel G., and Attias D. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure. Hum Reprod 14 (1999) 1624-1627
9. Glueck C.J., Wang P., Goldenberg N., and Sieve L. Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin. Clin Appl Thromb Hemost 10 (2004) 323-334
10. Dudding T.E., and Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 91 (2004) 700-711
11. Rey E., Kahn S.R., David M., and Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361 (2003) 901-908
12. Krabbendam I., Franx A., Bots M.L., Fijnheer R., and Bruinse H.W. Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature. Eur J Obstet Gynecol Reprod Biol 118 (2005) 143-153
13. Carp H., Salomon O., Seidman D., Dardik R., Rosenberg N., and Inbal A. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod 17 (2002) 1633-1637
14. Kutteh W.H., Park V.M., and Deitcher S.R. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 71 (1999) 1048-1053
15. Rai R., Shlebak A., Cohen H., Backos M., Holmes Z., Marriott K., et al. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 16 (2001) 961-965
16. Dizon-Townson D., Miller C., Sibai B., Spong C.Y., Thom E., Wendel Jr. G., et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 106 (2005) 517-524
17. van Dunne F.M., Doggen C.J., Heemskerk M., Rosendaal F.R., and Helmerhorst F.M. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis. Hum Reprod 20 (2005) 802-806
18. Brenner B., Hoffman R., Blumenfeld Z., Weiner Z., and Younis J.S. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 83 (2000) 693-697
19. Carp H., Dolitzky M., and Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost 1 (2003) 433-438
20. Kupferminc M.J., Fait G., Many A., Lessing J.B., Yair D., Bar-Am A., et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy 20 (2001) 35-44
21. Gris J.C., Mercier E., Quere I., Lavigne-Lissalde G., Cochery-Nouvellon E., Hoffet M., et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 103 (2004) 3695-3699
22. Di Nisio M., Peters L., and Middeldorp S. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database Syst Rev (2005) CD004734
23. Wu O., Robertson L., Twaddle S., Lowe G.D., Clark P., Greaves M., et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 10 (2006) 1-110
24. Glueck C.J., Pranikoff J., Aregawi D., Haque M., Zhu B., Tracy T., et al. The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage. Metabolism 54 (2005) 1345-1349
25. Bick R.L., and Hoppensteadt D. Recurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: a review and update. Clin Appl Thromb Hemost 11 (2005) 1-13
26. Ridker P.M., Miletich J.P., Hennekens C.H., and Buring J.E. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 277 (1997) 1305-1307
27. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
28. Silver R.M. Fetal death. Obstet Gynecol 109 (2007) 153-167
29. Bricker L., and Farquharson R.G. Types of pregnancy loss in recurrent miscarriage: implications for research and clinical practice. Hum Reprod 17 (2002) 1345-1350
30. Porter T.F., and Scott J.R. Evidence-based care of recurrent miscarriage. Best Pract Res Clin Obstet Gynaecol 19 (2005) 85-101
31. Lee R.M., and Silver R.M. Recurrent pregnancy loss: summary and clinical recommendations. Semin Reprod Med 18 (2000) 433-440
32. Ogasawara M., Aoki K., Okada S., and Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 73 (2000) 300-304
33. Wapner R.J. Invasive prenatal diagnostic techniques. Semin Perinatol 29 (2005) 401-404
34. Drugan A., Koppitch III F.C., Williams III J.C., Johnson M.P., Moghissi K.S., and Evans M.I. Prenatal genetic diagnosis following recurrent early pregnancy loss. Obstet Gynecol 75 (1990) 381-384
35. Karypidis A.H., Soderstrom T., Nordmark A., Granath F., Cnattingius S., and Rane A. Association of cytochrome P450 1B1 polymorphism with first-trimester miscarriage. Fertil Steril 86 (2006) 1498-1503
36. SAS-STAT. Changes and enhancements through release 9.1 (2004), SAS Institute, Cary, NC
37. Balasa V.V., Gruppo R.A., Glueck C.J., Stroop D., Becker A., Pillow A., et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost 81 (1999) 739-744
38. Lissalde-Lavigne G., Fabbro-Peray P., Cochery-Nouvellon E., Mercier E., Ripart-Neveu S., Balducchi J.P., et al. Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control "NOHA First" study. J Thromb Haemost 3 (2005) 2178-2184
39. Lissalde-Lavigne G., Fabbro-Peray P., Mares P., and Gris J.C. More on: factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control "NOHA First" study. J Thromb Haemost 4 (2006) 1640-1642
40. Folkeringa N., Brouwer J.L., Korteweg F.J., Veeger N.J., Erwich J.J., Holm J.P., et al. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol 136 (2007) 656-661
41. Martinelli I., Taioli E., Cetin I., Marinoni A., Gerosa S., Villa M.V., et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 343 (2000) 1015-1018
42. Gris J.C., Quere I., Monpeyroux F., Mercier E., Ripart-Neveu S., Tailland M.L., et al. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent-the Nimes Obstetricians and Haematologists Study 5 (NOHA5). Thromb Haemost 81 (1999) 891-899
43. Rai R.S., Clifford K., Cohen H., and Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 10 (1995) 3301-3304
44. Preston F.E., Rosendaal F.R., Walker I.D., Briet E., Berntorp E., Conard J., et al. Increased fetal loss in women with heritable thrombophilia. Lancet 348 (1996) 913-916
45. Dizon-Townson D.S., Meline L., Nelson L.M., Varner M., and Ward K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 177 (1997) 402-405
46. Ridker P.M., Miletich J.P., Buring J.E., Ariyo A.A., Price D.T., Manson J.E., et al. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 128 (1998) 1000-1003
47. Grandone E., Margaglione M., Colaizzo D., d'Addedda M., Cappucci G., Vecchione G., et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 77 (1997) 822-824
48. Tormene D., Simioni P., Prandoni P., Luni S., Innella B., Sabbion P., et al. The risk of fetal loss in family members of probands with factor V Leiden mutation. Thromb Haemost 82 (1999) 1237-1239
49. Meinardi J.R., Middeldorp S., de Kam P.J., Koopman M.M., van Pampus E.C., Hamulyak K., et al. Increased risk for fetal loss in carriers of the factor V Leiden mutation. Ann Intern Med 130 (1999) 736-739
50. Marietta M., Facchinetti F., Sgarbi L., Simoni L., Bertesi M., Torelli G., et al. Elevated plasma levels of factor VIII in women with early recurrent miscarriage. J Thromb Haemost 1 (2003) 2536-2539
51. Glueck C.J., Awadalla S.G., Phillips H., Cameron D., Wang P., and Fontaine R.N. Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage. Fertil Steril 74 (2000) 394-397
52. Glueck C.J., Kupferminc M.J., Fontaine R.N., Wang P., Weksler B.B., and Eldor A. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 97 (2001) 44-48
53. Derksen R.H., and de Groot P.G. The obstetric antiphospholipid syndrome. J Reprod Immunol (2007)
54. Petri M., and Qazi U. Management of antiphospholipid syndrome in pregnancy. Rheum Dis Clin North Am 32 (2006) 591-607